FOLH1 and Familial prostate cancer: In the last years, tremendous investigations have been done for developing radioligands targeting prostate-specific-membrane antigen (PSMA) for the depiction of malignant tissues particularly in prostate cancer and several small-molecule tracers targeting PSMA have generated a lot of interest [25–27].